NurExone Biologic Inc. (NRX.V)

CA$0.46

CAD

+0.01(2.22%)

At close: Aug 05, 18:24 EDT

Recently from Cashu

Megatrend Nanotechnology – andNurExone Biologic Inc. at the Center ofthe Development

Nanotechnology is transforming industry and medicine – and NurExone Biologic Inc. is positioning itself at the heart of this future market with its exosome-based platform. With progress in reproducibl…

Cashu Markets·2 months ago

Open

CA$0.55

Prev. Close

CA$0.435

High

CA$0.55

Low

CA$0.55

Company Profile

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.

CEOLior Shaltiel

SectorHealthcare

IndustryBiotechnology

IPO DateSep 13, 2022

ExchangeTSXV

Exchange NameToronto Stock Exchange Ventures

CurrencyCAD

Headquarters & Contact

Address1 Adelaide Street East

City / State / ZIPToronto, ON, M5C 2V9

CountryCanada

Websitehttps://nurexone.com